Hexavalent recombinant norovirus vaccine (Kanghua Biological)

重组六价诺如病毒疫苗(康华生物)

Report date: 2024/12/17 13:48:13

Base Information

Drug NameHexavalent recombinant norovirus vaccine (Kanghua Biological)
Drug Alias NameHIL-216KH-002
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine +[5
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGastroenteritis norovirusGastroenteritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsGastroenteritis norovirusGastroenteritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A